title: Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.
authors.affiliation: Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
authors.forename: R
authors.initials: R
authors.lastname: Ridzon
authors.forename: J
authors.initials: J
authors.lastname: Meador
authors.forename: R
authors.initials: R
authors.lastname: Maxwell
authors.forename: K
authors.initials: K
authors.lastname: Higgins
authors.forename: P
authors.initials: P
authors.lastname: Weismuller
authors.forename: I M
authors.initials: IM
authors.lastname: Onorato
mesh_terms: D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000009:adverse effects*; D011718:Pyrazinamide / Q000009:adverse effects*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D015242:Ofloxacin; D000410:Alanine Transaminase